Subsequently, decreased CYLD expression and mutations of the CYLD genomic locus have been reported in a number of different cancers including colon, hepatocellular and myeloid malignancies, suggesting that CYLD exhibits broad tumour suppressor functions2, 3, 4, 5. This evidence concerns the gene CYLD and neoplasm.